Search research articles
Contact Us
Filters
Showing results (11-20 of 88) with videos related to
Page
of 9
Sort By:
Journal of Neurosurgery
|
April 25, 2020
Editorial. Community practice in the time of COVID-19
J Adair Prall, John D Davis, N Ross Jenkins
British Journal of Clinical Pharmacology
|
April 15, 2021
Blueprint for pandemic response: Focus on translational medicine, clinical pharmacology and pharmacometrics
Jasmine Davda, Kellie Reynolds, John D Davis, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
September 30, 2024
Population pharmacokinetic analyses of pozelimab in patients with CD55-deficient protein-losing enteropathy (CHAPLE disease)
Kuan-Ju Lin, Jeanne Mendell, John D Davis, et al.
Current Drug Metabolism
|
October 16, 2008
Grapefruit juice-drug interaction studies as a method to assess the extent of intestinal availability: utility and limitations
Michael Gertz, John D Davis, Anthony Harrison, et al.
American Journal of Obstetrics and Gynecology
|
May 1, 2012
The utility of endocervical curettage: does routine ECC at the time of colposcopy for low-grade cytologic abnormalities improve diagnosis of high-grade disease?
Joseph D Rose, Sharon Y Byun, Shireen Madani Sims, et al.
Biomedical Sciences Instrumentation
|
January 15, 2009
Bioinspired minimal machine multiaperture apposition vision system
John D Davis, Steven F Barrett, Cameron H G Wright, et al.
Biopharmaceutics & Drug Disposition
|
April 15, 2015
Projecting human pharmacokinetics of monoclonal antibodies from nonclinical data: comparative evaluation of prediction approaches in early drug development
Jing Wang, Suhasini Iyer, Paul J Fielder, et al.
British Journal of Clinical Pharmacology
|
March 26, 2008
Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects
John D Davis, Frances Hackman, Gary Layton, et al.
Antiviral Therapy
|
October 9, 2009
Pharmacokinetics, safety and tolerability of a single oral dose of maraviroc in HIV-negative subjects with mild and moderate hepatic impairment
Samantha Abel, John D Davis, Caroline E Ridgway, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 29, 2021
Population pharmacokinetics and exposure-response modeling for evinacumab in homozygous familial hypercholesterolemia
Xia Pu, Mark Sale, Feng Yang, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 88) with videos related to
Sort By:
Page
of 9
Journal of Neurosurgery
|
April 25, 2020
Editorial. Community practice in the time of COVID-19
J Adair Prall, John D Davis, N Ross Jenkins
British Journal of Clinical Pharmacology
|
April 15, 2021
Blueprint for pandemic response: Focus on translational medicine, clinical pharmacology and pharmacometrics
Jasmine Davda, Kellie Reynolds, John D Davis, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
September 30, 2024
Population pharmacokinetic analyses of pozelimab in patients with CD55-deficient protein-losing enteropathy (CHAPLE disease)
Kuan-Ju Lin, Jeanne Mendell, John D Davis, et al.
Current Drug Metabolism
|
October 16, 2008
Grapefruit juice-drug interaction studies as a method to assess the extent of intestinal availability: utility and limitations
Michael Gertz, John D Davis, Anthony Harrison, et al.
American Journal of Obstetrics and Gynecology
|
May 1, 2012
The utility of endocervical curettage: does routine ECC at the time of colposcopy for low-grade cytologic abnormalities improve diagnosis of high-grade disease?
Joseph D Rose, Sharon Y Byun, Shireen Madani Sims, et al.
Biomedical Sciences Instrumentation
|
January 15, 2009
Bioinspired minimal machine multiaperture apposition vision system
John D Davis, Steven F Barrett, Cameron H G Wright, et al.
Biopharmaceutics & Drug Disposition
|
April 15, 2015
Projecting human pharmacokinetics of monoclonal antibodies from nonclinical data: comparative evaluation of prediction approaches in early drug development
Jing Wang, Suhasini Iyer, Paul J Fielder, et al.
British Journal of Clinical Pharmacology
|
March 26, 2008
Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects
John D Davis, Frances Hackman, Gary Layton, et al.
Antiviral Therapy
|
October 9, 2009
Pharmacokinetics, safety and tolerability of a single oral dose of maraviroc in HIV-negative subjects with mild and moderate hepatic impairment
Samantha Abel, John D Davis, Caroline E Ridgway, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 29, 2021
Population pharmacokinetics and exposure-response modeling for evinacumab in homozygous familial hypercholesterolemia
Xia Pu, Mark Sale, Feng Yang, et al.
Page
of 9